AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Study NCT05347277 — intervention group
Intervention type: DIAGNOSTIC_TEST
Intervention: Kappa Free Light Chain (K-FLC)
Description: A biochemical test measured on CSF sample via nephelometry on Beckman Immage-800 analyzer using kits from Freelite, The Binding Site, according to the manufacturer's instructions.
Study NCT05642000 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: SASEA HUB
Description: SASEA HUB website, an intervention tool to increase COVID-19 testing
Study NCT06306846 — intervention group
Intervention type: RADIATION
Group type: EXPERIMENTAL
Intervention: SBRT+immunochemotherpy
Description: SBRT radiotherapy，followed with PD-1 monoclonal antibody and TP chemotherapy
Study NCT06306846 — intervention group
Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Immunochemotherapy
Description: PD-1 monoclonal antibody and TP chemotheapy
Study NCT06306846 — intervention group
Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: cetuximab+immunochemotharpy
Description: PD-1 monoclonal antibody and TP chemotheapy combined with cetuximab
Study NCT06457607 — intervention group
Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: LinearZ
Description: High Intensity Focues Ultrasound
Study NCT06063330 — intervention group
Intervention type: COMBINATION_PRODUCT
Group type: EXPERIMENTAL
Intervention: RQ-001
Description: Drug product RQ-001 is the fully assembled device consisting of the vial containing RQ-01 and the actuator. Drug Product RQ-001 has been developed with an Aptar Bidose liquid nasal spray unit device (BDSI V3) capable of intranasally delivering a 200 uL total volume of drug product (specifically, 100 uL per nare, which delivers a 200 uL of total volume). The combination product comprises the drug constituent (RQ-01) and the assembly of commercially available, off-the-shelf device components.~Study staff will be responsible for assembling the drug product RQ-001 and subjects will self-administer under the supervision of study staff in the clinic.
Study NCT06063330 — intervention group
Intervention type: OTHER
Group type: PLACEBO_COMPARATOR
Intervention: Placebo
Description: Matching placebo will be manufactured just as RQ-01 drug substance, with the active ingredient addition step omitted. Placebo will appear similar to RQ-01 drug substance as a clear to hazy, colorless to yellowish liquid. Matching placebo will be administered the same way as RQ-01
Study NCT05668091 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Nirmatrelvir
Description: Two 150 mg tablets taken by mouth every 12 hours.
Study NCT05668091 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Ritonavir
Description: One 100 mg capsule taken by mouth every 12 hours.
Study NCT05668091 — intervention group
Intervention type: DRUG
Group type: PLACEBO_COMPARATOR
Intervention: Ritonavir
Description: One 100 mg capsule taken by mouth every 12 hours.
Study NCT05668091 — intervention group
Intervention type: DRUG
Group type: PLACEBO_COMPARATOR
Intervention: Placebo
Description: Two tablets containing placebo matching nirmatrelvir taken by mouth every 12 hours.
Study NCT04188288 — intervention group
Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: Experimental feedback
Description: Participants provided with feedback of target brain activation patterns (for example, in the form of a line graph) and will be instructed to try to make the line go up or down.
Study NCT04188288 — intervention group
Intervention type: DEVICE
Group type: OTHER
Intervention: Control feedback
Description: Participants provided with control type of feedback (for example, in the form of a line graph) and will be instructed to try to make the line go up or down.
Study NCT04188288 — intervention group
Intervention type: DEVICE
Group type: OTHER
Intervention: fMRI
Description: fMRI will be used to assess brain activity
Study NCT04188288 — intervention group
Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: fMRI
Description: fMRI will be used to assess brain activity
Study NCT06209060 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Hammock Position
Description: Researchers will make a hammock by using a soft rectangular cotton cloth with ropes that pass through the circular openings of the incubator and are tied on the upper part of it. Babies will be placed in this hammock in a supine position with their extremities in the midline. The spine of the preterm neonate will support while arms and knees are flexed. Additionally, a small rectangular roller will be placed between the cervical and scapular region of the newborn in the hammock position to ensure that no hyperflexion or hyperextension position of the head occurs, which may impair respiratory function.
Study NCT06209060 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Nesting
Description: In the nesting group, a nest will be made using rolls prepared with materials such as towels and blankets, and the baby will be placed in this nest. The baby's head and body will be positioned on the same axis, its extremities will be positioned in the midline, and its hands will be positioned close to its face.
Study NCT06630624 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: IP-001
Description: Intra-tumoral injection of IP-001 following ablation (RFA, MWA or IRE).
Study NCT06629870 — intervention group
Intervention type: DEVICE
Group type: ACTIVE_COMPARATOR
Intervention: virtual reality
Description: patients who received distraction using virtual reality glasses
Study NCT06629870 — intervention group
Intervention type: OTHER
Group type: PLACEBO_COMPARATOR
Intervention: control group
Description: no any anxiety-reducing application
Study NCT06629870 — intervention group
Intervention type: OTHER
Group type: ACTIVE_COMPARATOR
Intervention: hypnotherapy
Description: patients receiving hypnotherapy
Study NCT06629870 — intervention group
Intervention type: OTHER
Group type: ACTIVE_COMPARATOR
Intervention: mindfulness
Description: patients who underwent mindfulness-based meditation
Study NCT06555367 — intervention group
Intervention type: DEVICE
Intervention: scleral lenses
Description: Wear scleral lenses
Study NCT05105659 — intervention group
Intervention type: DIAGNOSTIC_TEST
Intervention: Wechsler IQ for Adults
Description: IQ test that measures the cognitive functions and intelligence using a scale and consists of many subtests assessing verbal and non-verbal performance.
Study NCT05105659 — intervention group
Intervention type: DIAGNOSTIC_TEST
Intervention: MAS (Memory assessment scale)
Description: tool that uses verbal and the visual tasks to assess memory, recall and cognition. The MAS consists of 12 subtests based on the following 7 memory tasks: Verbal Span, List Learning, Prose memory, Visual Span, Visual Recognition, Visual Reproduction and Names-Faces.
Study NCT05105659 — intervention group
Intervention type: DIAGNOSTIC_TEST
Intervention: Health-Related Quality of Life (HRQoL)
Description: measures multiple aspects of the individual's life and the impact of the disease and treatment on the individual's life. It does so by assessing the individual's own views and perspective of the care and treatment they are receiving and whether consider it satisfactory or not.
Study NCT05105659 — intervention group
Intervention type: DIAGNOSTIC_TEST
Intervention: Symptom check list 90
Description: a well-known scale that is used to identify and assess psychological symptoms. It consists of a 90-item checklist having a 5-point rating scale.
Study NCT05105659 — intervention group
Intervention type: DIAGNOSTIC_TEST
Intervention: Socioeconomic level
Description: scale for measurement of socioeconomic status in health research in Egypt. The new socioeconomic status scale has 7 domains with a total score of 84. Intra-and inter-observer variability and the internal consistency of the scale were assessed.
Study NCT05103657 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: BI 1358894
Description: BI 1358894
Study NCT05103657 — intervention group
Intervention type: DRUG
Group type: PLACEBO_COMPARATOR
Intervention: Placebo
Description: Placebo
Study NCT05920187 — intervention group
Intervention type: OTHER
Group type: ACTIVE_COMPARATOR
Intervention: Mediterranean diet and Anti-inflammatory diet
Description: Cases will be randomly allocated to two groups: Mediterranean diet group (following dietary intervention based on MD), and Anti_inflammatory diet group(following dietary intervention based on IBD-AIF). Patients of the control group will not be instructed to follow a specific dietary intervention.~Evaluation of adherence of cases to dietary intervention will be at two points of time: after four weeks and after 12 weeks by using Mediterranean Diet Serving Score (MDSS) for MD adherence and Anti- Inflammatory Diet Serving Score for IBD- AID adherence. The AID Serving Score (AIDSS) is based on the latest update of the Anti-Inflammatory Diet Pyramid, using the recommended consumption frequency of foods and food group.
Study NCT06163521 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Education
Description: A training consisting of 8 sessions of 40 minutes each will be applied to the children. One session will be done every week. The training will consist of activities including information, discussion and role-playing about children with special needs. The training topics consist of; Children with Special Needs Empathy Differences, Respect for Differences Contact Activity Awareness Benevolence Social Acceptance and Behaviour What can we do?
Study NCT04622527 — intervention group
Intervention type: OTHER
Group type: ACTIVE_COMPARATOR
Intervention: Random assigned paradigm viewing order
Description: Participants experience the paradigm in a random order
Study NCT04776356 — intervention group
Intervention type: DEVICE
Intervention: QuickFix Small Staple (Arthrex)
Description: The Arthrex QuickFix Small Staple enables the surgeon to perform a wedge osteotomy of the first phalanx (Akin). The device is made of stainless steel and designed with barbed leg tips. The staple sizes are 8 and 10 mm wide with a 1 mm diameter.
Study NCT04622527 — intervention group
Intervention type: OTHER
Group type: SHAM_COMPARATOR
Intervention: Random assigned paradigm viewing order
Description: Participants experience the paradigm in a random order
Study NCT06018519 — intervention group
Intervention type: OTHER
Group type: OTHER
Intervention: Cognitive assessments
Description: 19- Leiter 3 scale (4 cognitive sub-tests to be able to compute the non-verbal IQ and 2 non-verbal memory sub-tests) or Bayley 4 if Leiter 3 is not possible~20- CPM-BF~21- Simple reasoning task on tablet (match-to-sample task)~22- Implicit rules learning (modified Brixton),~23- 4 sub-tests from the WPPSI-IV (zoo location to assess spatial memory, block design to assess visuo-constructive abilities, bug search , cancellation),~24- Attention assessment (4 sub-tests from KITTAP: alert, go/no go, flexibility, divided attention),~25- Elementary visuo-spatial perception (on tablets)
Study NCT05471167 — intervention group
Intervention type: BIOLOGICAL
Intervention: BCG
Description: Exposure is defined as having received the BCG vaccine during the first year of life.
Study NCT06018519 — intervention group
Intervention type: OTHER
Group type: OTHER
Intervention: Language assessments
Description: 26- EXALANG 3-6 (10 sub-tests testing for expressive and receptive language assessments),~27- PPVT-5 (receptive vocabulary), EVT-3 (expressive vocabulary),~28- Automatic language analysis (during a 10 minutes interaction, play).
Study NCT06018519 — intervention group
Intervention type: OTHER
Group type: OTHER
Intervention: Motor assessments
Description: 29- Kinematic task (specifically designed),~30- Purdue-Pegboard test,~31- Renzi test
Study NCT06018519 — intervention group
Intervention type: OTHER
Group type: OTHER
Intervention: Social assessments
Description: 32- Eye-tracking analysis of social visual scenes and social preference index (movies),~33- theory of mind assessment,~34- ADOS scale (Autism Spectrum Disorder),~35- sensitivity to inequality,~36- pro-social behaviors (help of the psychologist)
Study NCT05569486 — intervention group
Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: Green Light
Description: This is a low-energy device. It produces almost no heat because it uses an LED source for light. The device does not store energy or electrical power that can be discharged later.
Study NCT05569486 — intervention group
Intervention type: DEVICE
Group type: PLACEBO_COMPARATOR
Intervention: Green Light
Description: This is a low-energy device. It produces almost no heat because it uses an LED source for light. The device does not store energy or electrical power that can be discharged later.
Study NCT05560776 — intervention group
Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: Endobronchial ultrasound
Description: Two or three passes per lymph node
Study NCT05034718 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: PIBIS clinical decision support
Description: The intervention is the presence of the PIBIS physician alert and powerform, which is clinical decision support for the treating provider if a patient meets inclusion criteria for Pittsburgh Infant Brain Injury Score (PIBIS) calculation.
Study NCT06018519 — intervention group
Intervention type: OTHER
Group type: OTHER
Intervention: 3T MRI
Description: 37- Structural, metabolic and functional data
Study NCT06018519 — intervention group
Intervention type: OTHER
Group type: OTHER
Intervention: Cardiac assessments
Description: 38- ECG~39- Ultrasound
Study NCT06018519 — intervention group
Intervention type: OTHER
Group type: OTHER
Intervention: Biological collection
Description: 40- Blood sample~41- Urinary sample~42- Superficial skin biopsy
Study NCT05034718 — intervention group
Intervention type: OTHER
Group type: ACTIVE_COMPARATOR
Intervention: Standard of care
Description: Standard of care, absent the PIBIS powerform and alert for providers.
Study NCT05955053 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Midwifery care applied in line with Midwife-Pregnant cooperation
Description: Pregnant women who apply to the obstetrics clinic will be informed about the research by the doctor and the pregnant woman whose labor has started will be sent to the delivery room. The researcher will be welcomed by the midwife from the first time the pregnant woman arrives in labor (delivery room), and firstly she will be informed about the purpose of the research and an informative consent form and a pregnant identification form will be filled in that she agrees to participate in the research. During labor and labor, the research midwife (HYY) will be with a pregnant woman until she gives birth and care will be given according to the items in the midwifery care checklist prepared based on the partnership model. After giving birth to a pregnant woman and applying the scales, another pregnant woman will be transferred and care will be given in the same way according to the midwifery care model checklist.
Study NCT05782712 — intervention group
Intervention type: BIOLOGICAL
Intervention: adenosine dosage
Description: Whole blood is collected using finger puncture followed by deposit a drop of blood (20 μL) using finnpipette, on a blotting paper (Whatman 903 protein saver cards™) and dried over night at room temperature to obtain dried blood spot (DBS).
Study NCT06105931 — intervention group
Intervention type: BIOLOGICAL
Group type: EXPERIMENTAL
Intervention: Hyperinsulinemic-euglycemic clamp
Description: Hyperinsulinemic-euglycemic clamp will be used to assess insulin resistance. After IVs are placed, participants will be transitioned to intravenous insulin administration for the baseline portion of the study. Stable Isotope Tracer Infusions will assess rates of glucose, lipid metabolism, and beta-hydroxybutyrate turnover during the last 30 minutes of the baseline equilibration period and again during the last 30 minutes of the stepped IV insulin infusion periods.
Study NCT06105931 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: High Fat Mixed Meal Tolerance Test
Description: After a 12 hour overnight fast, baseline levels of the lipoproteins will be drawn. The YCCI Bionutrition Service kitchen will prepare the standardized high-fat meal. Participants will administer their bolus insulin per their home regimen for the carbohydrates in the high-fat meal, and then they will consume the meal within a 15-minute timeframe.
Study NCT05846711 — intervention group
Intervention type: DIAGNOSTIC_TEST
Group type: ACTIVE_COMPARATOR
Intervention: BPPV diagnostic
Description: Supine Roll Test and Dix-Hallpike Test
Study NCT05846711 — intervention group
Intervention type: DEVICE
Group type: ACTIVE_COMPARATOR
Intervention: TRV chair
Description: Mechanical rotational chair
Study NCT05846711 — intervention group
Intervention type: DEVICE
Group type: ACTIVE_COMPARATOR
Intervention: VNG goggles
Description: Goggles for video nystagmography
Study NCT05846711 — intervention group
Intervention type: DEVICE
Group type: ACTIVE_COMPARATOR
Intervention: IMU sensor
Description: A sensor that measures triaxial acceleration and triaxial angular velocity.
Study NCT05846711 — intervention group
Intervention type: PROCEDURE
Group type: ACTIVE_COMPARATOR
Intervention: Manual BPPV diagnostics
Description: Bedside BPPV diagnostics
Study NCT05597397 — intervention group
Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: RLRL
Description: In addition to SVS with power for correcting distance refraction, RLRL will be performed twice per school day with an interval of at least 4 hours, each treatment last 3 minutes.
Study NCT06145646 — intervention group
Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: Muscle warm-up
Description: Passive heating of the vastus lateralis of the right quadriceps will be performed using a microwave device. The device will be set at a power of 150 W and a distance of 10-15 cm from the skin surface for 20 minutes with the purpose of increasing local muscle temperature to 40 ºC.
Study NCT05505500 — intervention group
Intervention type: BEHAVIORAL
Intervention: Interview
Description: Concept Elicitation Interviews are used to create tools followed by Cognitive Debrief Interviews that are used to review created tools.
Study NCT06502418 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Acupuncture therapy
Description: 7 acupuncture points will be used to managed pain and improved patient's experience
Study NCT06551922 — intervention group
Intervention type: COMBINATION_PRODUCT
Group type: EXPERIMENTAL
Intervention: Instrumental Soft Tissue Mobilization Technique with Conservative Treatment
Description: TENS: Apply TENS for 10 minutes on the greater trochanter and the area just above the lateral knee joint line, adhesive electrodes will be positioned.~Frequency: 3 times per week. Duration: 90 seconds- 2 minutes on each muscle (Purbia, 2023). Technique: A therapist uses Ergon tools to apply gentle pressure and strokes along the targeted muscles and fascial tissues. Different IASTM techniques, like stroking, raking, and hooking, address specific tissue restrictions. The therapist should continue the IASTM technique for 5-10 minutes, or until the stiffness in the knee is reduced (Mubashar et al., 2022; Purbia, 2023).~Conservative Treatment: Stretching exercises for the hamstrings and quadriceps to improve flexibility and reduce tension. Affected iliotibialband. Hold for 30 seconds. Uncross your legs and stand up straight again. Repeat four more times (Mubashar et al., 2022).
Study NCT06551922 — intervention group
Intervention type: COMBINATION_PRODUCT
Group type: EXPERIMENTAL
Intervention: Conservative Treatment
Description: TENS: Apply TENS for 10 minutes on the greater trochanter and the area just above the lateral knee joint line, adhesive electrodes will be positioned.~Stretching exercises with hold for 30 seconds. Uncross your legs and stand up straight again (Mubashar et al., 2022).~Quadriceps Strengthening: Perform exercises like straight leg raises, seated leg press and squats to strengthen (Lim \& Al-Dadah, 2022).~Hamstring Strengthening: Include exercises like leg curls to strengthen the hamstring muscles (Lim \& Al-Dadah, 2022).~Calf Strengthening: Perform calf raises to strengthen the calf muscles (Lim \& Al-Dadah, 2022).~Balance Exercises: Incorporate balance exercises like single-leg stands on a foam pad (Lim \& Al-Dadah, 2022).~Ice Therapy: Apply ice packs to the affected knee for 15-20 minutes (Lim \& Al-Dadah, 2022).
Study NCT06325631 — intervention group
Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: Intra-articular injection to lumbar facet joint
Description: to treat low back pain caused by facet joint syndrome
Study NCT06337032 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: F/TAF (High Dose Tablet)
Description: 200/25 mg fixed-dose combination (FDC) tablet administered orally
Study NCT06337032 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: F/TAF (Low Dose Tablet)
Description: 200/10 mg FDC tablet administered orally
Study NCT06337032 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: F/TAF (Lowest Dose Tablet)
Description: 120/15 mg FDC tablet administered orally
Study NCT06337032 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: F/TAF (High Dose TOS)
Description: 60/7.5 mg tablet for oral suspension (TOS) administered orally
Study NCT06337032 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: F/TAF (Low Dose TOS)
Description: 30/3.75 mg TOS administered orally
Study NCT06337032 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: F/TAF (Lowest Dose TOS)
Description: 15/1.88 mg TOS administered orally
Study NCT06337032 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: E/C/F/TAF
Description: 150/150/200/10 mg tablet administered orally
Study NCT06337032 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: E/C/F/TAF (Low Dose)
Description: 90/90/120/6 mg tablet administered orally
Study NCT06337032 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Cobicistat (High Dose)
Description: 150 mg tablet administered orally
Study NCT06337032 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Cobicistat (Low Dose)
Description: 90 mg tablet administered orally
Study NCT06337032 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Cobicistat (TOS)
Description: 30 mg TOS administered orally
Study NCT06337032 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: B/F/TAF (High Dose)
Description: 50/200/25 mg FDC tablet administered orally
Study NCT04340531 — intervention group
Intervention type: OTHER
Group type: ACTIVE_COMPARATOR
Intervention: Best Practice
Description: Receive usual care
Study NCT04340531 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Survey Administration
Description: Ancillary studies
Study NCT04340531 — intervention group
Intervention type: OTHER
Group type: ACTIVE_COMPARATOR
Intervention: Survey Administration
Description: Ancillary studies
Study NCT04340531 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Tobacco Cessation Counseling
Description: Receive referred to counseling session
Study NCT04340531 — intervention group
Intervention type: OTHER
Group type: ACTIVE_COMPARATOR
Intervention: Tobacco Cessation Counseling
Description: Receive referred to counseling session